These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12369494)

  • 1. The discriminative value of C-reactive protein levels in distinguishing between community-acquired bacteraemic and respiratory virus-associated lower respiratory tract infections in HIV-1-infected and -uninfected children.
    Lala SG; Madhi SA; Pettifor JM
    Ann Trop Paediatr; 2002 Sep; 22(3):271-9. PubMed ID: 12369494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
    Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
    Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children.
    Madhi SA; Petersen K; Madhi A; Khoosal M; Klugman KP
    Clin Infect Dis; 2000 Jul; 31(1):170-6. PubMed ID: 10913417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.
    Hohenthal U; Hurme S; Helenius H; Heiro M; Meurman O; Nikoskelainen J; Kotilainen P
    Clin Microbiol Infect; 2009 Nov; 15(11):1026-32. PubMed ID: 19548923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
    Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
    BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study.
    Higdon MM; Le T; O'Brien KL; Murdoch DR; Prosperi C; Baggett HC; Brooks WA; Feikin DR; Hammitt LL; Howie SRC; Kotloff KL; Levine OS; Scott JAG; Thea DM; Awori JO; Baillie VL; Cascio S; Chuananon S; DeLuca AN; Driscoll AJ; Ebruke BE; Endtz HP; Kaewpan A; Kahn G; Karani A; Karron RA; Moore DP; Park DE; Rahman MZ; Salaudeen R; Seidenberg P; Somwe SW; Sylla M; Tapia MD; Zeger SL; Deloria Knoll M; Madhi SA;
    Clin Infect Dis; 2017 Jun; 64(suppl_3):S378-S386. PubMed ID: 28575375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.
    Holm A; Pedersen SS; Nexoe J; Obel N; Nielsen LP; Koldkjaer O; Pedersen C
    Br J Gen Pract; 2007 Jul; 57(540):555-60. PubMed ID: 17727748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.
    Bhuiyan MU; Blyth CC; West R; Lang J; Rahman T; Granland C; de Gier C; Borland ML; Thornton RB; Kirkham LS; Martin A; Richmond PC; Smith DW; Jaffe A; Snelling TL
    BMC Pulm Med; 2019 Apr; 19(1):71. PubMed ID: 30940126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review.
    Engel MF; Paling FP; Hoepelman AI; van der Meer V; Oosterheert JJ
    Fam Pract; 2012 Aug; 29(4):383-93. PubMed ID: 22159030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the quick-read C-reactive protein test in the prediction of bacterial pneumonia in the pediatric emergency department.
    Marcus N; Mor M; Amir L; Mimouni M; Waisman Y
    Eur J Emerg Med; 2008 Jun; 15(3):158-61. PubMed ID: 18460957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.
    Holm A; Nexoe J; Bistrup LA; Pedersen SS; Obel N; Nielsen LP; Pedersen C
    Br J Gen Pract; 2007 Jul; 57(540):547-54. PubMed ID: 17727747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings.
    Heiskanen-Kosma T; Korppi M
    Scand J Infect Dis; 2000; 32(4):399-402. PubMed ID: 10959648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study.
    Mendelson F; Griesel R; Tiffin N; Rangaka M; Boulle A; Mendelson M; Maartens G
    BMC Infect Dis; 2018 Aug; 18(1):399. PubMed ID: 30107791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of inflammatory markers in predicting the aetiology of pneumonia in children.
    Elemraid MA; Rushton SP; Thomas MF; Spencer DA; Gennery AR; Clark JE
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):458-62. PubMed ID: 24857169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of neutrophil CD64 in the diagnosis of community acquired pneumonia in children].
    Cai Q; Xu MY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov; 14(11):819-22. PubMed ID: 23146726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of bacterial and viral community-acquired pneumonia in children.
    Don M; Valent F; Korppi M; Canciani M
    Pediatr Int; 2009 Feb; 51(1):91-6. PubMed ID: 19371285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial.
    Fuchs A; Gotta V; Decker ML; Szinnai G; Baumann P; Bonhoeffer J; Ritz N;
    Clin Microbiol Infect; 2018 Dec; 24(12):1341.e1-1341.e7. PubMed ID: 29555393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia.
    Madhi SA; Kohler M; Kuwanda L; Cutland C; Klugman KP
    Pediatr Infect Dis J; 2006 Jan; 25(1):30-6. PubMed ID: 16395099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and inflammatory markers in pediatric pneumonia: a prospective study.
    Berg AS; Inchley CS; Fjaerli HO; Leegaard TM; Lindbaek M; Nakstad B
    Eur J Pediatr; 2017 May; 176(5):629-638. PubMed ID: 28281094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.